Onyx Biotec Ltd
Listed
NSE SME
SME
Live Chart
| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
Market Maker
|
Awaited |
244,000
5.07% |
5.07%
|
₹1.49 |
|
QIB
|
Over 1.00x
|
2,278,000
47.36% |
47.36%
|
₹13.90 |
|
NII / HNI
|
Over 1.00x
|
688,000
14.3% |
14.3%
|
₹4.20 |
|
Retail
|
Over 1.00x
|
1,600,000
33.26% |
33.26%
|
₹9.76 |
| Total | 1.00x | 4,810,000 |
100% | ₹29.34 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| QIB | 2,278,000 | ₹13.90 |
47.36%
|
| Market Maker | 244,000 | ₹1.49 |
5.07%
|
| NII | 688,000 | ₹4.20 |
14.30%
|
| Retail | 1,600,000 | ₹9.76 |
33.26%
|
| Total | 4,810,000 | ₹29.34 |
100.00%
|
| QIB | NII | Retail | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor | Total QIB | Below ₹10L | Above ₹10L | Total NII | |||
| Allocation (shares) | — | — | — | — | — | 688,000 | 1,600,000 | 2,288,000 |
| Allotment price (₹) | 61 | 61 | 61 | 61 | 61 | 61 | 61 | 61 |
| No. of applications | — | — | — | — | — | — | — | — |
| No. of shares applied | — | — | — | — | — | — | — | — |
| Amount collected (₹Cr) | — | — | — | — | — | — | ₹9.76 | ₹9.76 |
| Times subscribed | 1 | — | — | — | — | 1 | 1 | 1 |
| Shares allotted | — | — | — | — | — | 688,000 | 1,600,000 | 2,288,000 |
| No. of allottees | — | — | — | — | — | — | — | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 4,000 | ₹244,000 |
| Retail (Max — 13 Lots) | 13 | 26,000 | ₹1,586,000 |
| S-HNI (Min — 14 Lots) | 14 | 28,000 | ₹1,708,000 |
| B-HNI (Min — 68 Lots) | 68 | 136,000 | ₹8,296,000 |
Onyx Biotec Ltd is proposing an IPO on NSE SME under the SME category. Total issue: 48,10,000 shares (aggregating up to ₹29.34 Cr).
Opens 13 Nov 2024, closes 18 Nov 2024. Listing: 22 Nov 2024. Apply via ASBA or UPI.
| Particulars | 31 May 2024 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue from Operations | 1054.11 | 5387.43 | 3961.65 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 130.77 | 303.16 | 184.46 |
| Net Worth | 2618.64 | 2487.87 | 1820.16 |
| Total Assets | 7476.57 | 7413.58 | 5872.36 |
| Reserves & Surplus | 1286.42 | 1155.65 | 1230.00 |
| Borrowings | 3156.14 | 3078.04 | 2922.83 |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | 12.42% | — | — |
Onyx Biotec Ltd IPO is subscribed 1.00 times by Nov 18, 2024. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Onyx Biotec Ltd IPO retail category is subscribed 1.00 times as of 18 Nov 2024. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 13 Nov 2024 and closes 18 Nov 2024. Min investment: ₹122,000 (1 lot = 2,000 shares). UPI mandate: 2024-11-18.
The Onyx Biotec Ltd IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 24 Nov 2024. Refunds: on 25 Nov 2024.
The Onyx Biotec Ltd IPO listing date is 22 Nov 2024, Friday. Listed on: NSE SME. Issue price: ₹61. Estimated listing: ₹61. GMP: NIL.
The Onyx Biotec Ltd IPO closes on 18 Nov 2024, Monday. UPI mandate: 2024-11-18. Allotment: 24 Nov 2024. Listing: 22 Nov 2024.